Stock-Based Compensation

$1.16M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$1.16Mperiod endingJun 30, 2026

MXCT Quarterly Stock-Based Comp ($1.15K → $1.16M)

Quarterly stock-based compensation

High-resolution chart · PNG

MXCT stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Maxcyte Inc Stock-Based Compensation — Quarterly (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	1,160,000
Mar 31, 2026	0
Dec 31, 2025	706,000
Sep 30, 2025	0
Jun 30, 2025	0
Mar 31, 2025	3,039,000
Dec 31, 2024	0
Sep 30, 2024	0
Jun 30, 2024	0
Mar 31, 2024	0
Dec 31, 2023	0
Sep 30, 2023	3,609,000
Jun 30, 2023	0
Mar 31, 2023	3,277,000
Dec 31, 2022	3,118,600
Sep 30, 2022	0
Jun 30, 2022	2,972,800
Mar 31, 2022	2,462,400
Dec 31, 2021	2,448,400
Sep 30, 2021	2,285,400
Jun 30, 2021	1,905,200
Mar 31, 2021	1,319,800
Dec 31, 2020	767,200
Sep 30, 2020	598,000
Jun 30, 2020	559,000
Mar 31, 2020	547,600
Dec 31, 2019	614,100
Sep 30, 2019	614,100
Jun 30, 2019	261,950
Mar 31, 2019	261,950
Dec 31, 2018	473,250
Sep 30, 2018	473,250
Jun 30, 2018	188,850
Mar 31, 2018	188,850
Dec 31, 2017	196,950
Sep 30, 2017	196,950
Jun 30, 2017	60,300
Mar 31, 2017	60,300
Dec 31, 2016	44,300
Sep 30, 2016	44,300
Jun 30, 2016	32,750
Mar 31, 2016	32,750
Dec 31, 2015	300
Sep 30, 2015	300
Jun 30, 2015	300
Mar 31, 2015	300
Dec 31, 2014	46,650
Sep 30, 2014	46,650
Jun 30, 2014	1,150
Mar 31, 2014	1,150